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  Gothenburg,	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  With	   increasing	   use	   of	   high	   resolution	   radiological	   imaging	   incidentally	   discovered	  adrenal	  tumours	  (adrenal	  incidentalomas,	  AI)	  have	  become	  a	  common	  clinical	  problem.	  The	  aim	  of	  work-­‐up	  and	  follow-­‐up	  of	  patients	  with	  AI	  is	  to	  detect	  malignant	  (primary	  or	  metastatic)	   and/or	  hormone-­‐producing	   tumours.	  The	   frequency	  of	  AI,	   and	   the	   clinical	  and	   patient	   reported	   outcomes	   of	   a	   two-­‐year	   follow-­‐up	   programme	   for	   AI	   was	  investigated	   in	   an	   unselected	   population	   undergoing	   radiology	   at	   all	   departments	   of	  radiology	   in	   Western	   Sweden	   during	   18	   months.	   The	   results	   of	   surgery	   for	   adrenal	  metastasis,	   and	   the	   impact	   of	   background	   variables	   on	   survival	   was	   analysed	   in	   a	  consecutive	   series	   of	   patients	   treated	   at	   the	   Sahlgrenska	   University	   Hospital	   (1996-­‐2007).	  Pheochromocytomas	  (Pheo)	  and	  paragangliomas	  (PGL)	  are	  rare	  catecholamine-­‐producing	   tumours	   originating	   from	   the	   adrenal	   medulla	   and	   sympathetic	   and	  parasympathetic	   ganglia	   that	   may	   be	   detected	   as	   AI.	   The	   frequency	   of	   germ-­‐line	  mutations	   (in	   the	  RET-­,	  SDHB-­,	  SDHC-­,	  SDHD-­	  and	  VHL-­genes)	  was	  studied	   in	  all	   living	  patients	   with	   Pheo	   and	   abdominal	   PGL	   with	   apparently	   sporadic	   presentation	  registered	  in	  the	  National	  Cancer	  Register	  for	  Western	  Sweden	  1958-­‐2009.	  	  At	  focused	  evaluation	  of	  abdominal	  computed	  tomography	  the	  frequency	  of	  AI	  was	  4.5	  %.	   In	   patients	   with	   AI	   (without	   extra-­‐adrenal	   malignancy)	   6.6	   %	   were	   operated	   on	  suspicion	   of	   malignant	   or	   hormone-­‐producing	   tumours;	   hormone-­‐producing	   tumours	  were	   verified	   in	   3.1	  %.	   No	   primary	   adrenal	   malignancy	   was	   found.	   All	   patients	   with	  hormone-­‐producing	   or	  malignant	   tumours	  were	   identified	   at	   first	   evaluation.	   Further	  follow-­‐up	   had	   low	   impact	   on	   Health-­‐Related	   Quality	   of	   Life,	   but	   did	   not	   confer	   any	  benefit.	  Surgery	  for	  adrenal	  metastasis	  was	  associated	  with	  low	  perioperative	  morbidity	  and	   mortality.	   Factors	   associated	   with	   prolonged	   survival	   were	   potentially	   curative	  surgery,	  tumour	  type,	  no	  previous	  surgery	  for	  metastases,	  and	  long	  disease-­‐free	  interval.	  It	  should	  be	  considered	  for	  all	  patients	  with	  isolated	  adrenal	  metastasis,	  and	  may	  be	  part	  of	  the	  multi-­‐modal	  treatment	  in	  disseminated	  disease.	  Germ-­‐line	  mutations	  were	  found	  in	   5.6	  %	  of	   patients	  with	   apparently	   sporadic	   Pheo/abdominal	   PGL,	  which	  was	   fewer	  than	   in	  other	  published	  series.	  All	  mutations	  were	  seen	   in	  SDHB	   and	  RET.	  Notably,	  no	  patient	  with	  SDHB-­‐mutation	  has	  evidence	  of	  malignant	  disease	  after	  16-­‐28	  years	  follow-­‐up,	  even	  though	  this	  genotype	  has	  been	  associated	  with	  a	  high	  rate	  of	  malignancy.	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